Methylene blue modulates transendothelial migration of peripheral blood cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Werner, Isabella ^a   Guo, Fengwei ^a   Bogert, Nicolai V ^a   Stock, Ulrich A ^a   Meybohm, Patrick ^a   Moritz, Anton ^a   Beiras Fernandez, Andres ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOCORTIN 5; LIPOPOLYSACCHARIDE; METHYLENE BLUE; N(G) METHYLARGININE; PROPIDIUM IODIDE;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BLOOD CELL; CELL MIGRATION ASSAY; CELL STIMULATION; CELL SUBPOPULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EXPOSURE; DRUG PROTEIN BINDING; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL LINE; MICROVASCULAR ENDOTHELIAL CELL; MIGRATION INHIBITION; MONOCYTE; PROTEIN EXPRESSION; PROTEIN SECRETION; REACTION TIME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; STIMULUS RESPONSE; T LYMPHOCYTE; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; CELLS, CULTURED; CYCLIC GMP; ENDOTHELIAL CELLS; ENZYME INHIBITORS; ERYTHROCYTES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; METHYLENE BLUE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84892412690     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082214     Document Type: Article

References (51)

1. Levin MA, Lin HM, Castillo JG, Adams DH, Reich DL, et al. (2009) Early oncardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation 120: 1664-1671.
2. Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, et al. (2004) Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 77: 496-499.
3. Ozal E, Kuralay E, Yildirim V, Kilic S, Bolcal C, et al. (2005) Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg 79: 1615-1619.
4. Shanmugam G (2005) Vasoplegic syndrome - the role of methylene blue. Eur J Cardiothorac Surg 28: 705-710.
5. Lenglet S, Mach F, Montecucco F (2011) Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery. Expert Rev Cardiovasc Ther 9: 1519-1525.
6. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, et al. (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36: 296-327.
7. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA (2001) The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27: 1416-1421.
8. Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A (2003) High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31: 2646-2650.
9. Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E (2003) The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 97: 1756-1763.
10. Polito A, Parisini E, Ricci Z, Picardo S, Annane D (2012) Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. Intensive Care Med 38: 9-19.
11. Mebazaa A, Pitsis AA, Rudiger A, Toller W, Longrois D, et al. (2010) Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care 14: 201.
12. Rees DD, Palmer RM, Moncada S (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A 86: 3375-3378.
13. Busse R, Mulsch A (1990) Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 275: 87-90.
14. Schulz R, Nava E, Moncada S (1992) Induction and potential biological relevance of a Ca(2 +)-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105: 575-580.
15. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
16. Thelen KI, Dembinska-Kiec A, Pallapies D, Simmet T, Peskar BA (1992) Effect of 3-morpholinosydnonimine (SIN-1) and NG-nitro-L-arginine (NNA) on isolated perfused anaphylactic guinea-pig hearts. Naunyn Schmiedebergs Arch Pharmacol 345: 93-99.
17. Mitsuhata H, Shimizu R, Yokoyama MM (1995) Role of nitric oxide in anaphylactic shock. J Clin Immunol 15: 277-283.
18. FDA Drug Safety Communication.
19. Evora PR (2000) Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock? J Thorac Cardiovasc Surg 119: 632-634.
20. Mayer B, Brunner F, Schmidt K (1993) Novel actions of methylene blue. Eur Heart J 14 Suppl I: 22-26.
21. Evora PR, Ribeiro PJ, Vicente WV, Reis CL, Rodrigues AJ, et al. (2009) Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties. Rev Bras Cir Cardiovasc 24: 279-288.
22. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, et al. (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683-690.
23. Schneider U, Schwenk HU, Bornkamm G (1977) Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 19: 621-626.
24. Reichert T, DeBruyere M, Deneys V, Totterman T, Lydyard P, et al. (1991) Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopathol 60: 190-208.
25. Taylor KM (1996) SIRS-the systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61: 1607-1608.
26. Vutskits L, Briner A, Klauser P, Gascon E, Dayer AG, et al. (2008) Adverse effects of methylene blue on the central nervous system. Anesthesiology 108: 684-692.
27. Ramsay RR, Dunford C, Gillman PK (2007) Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol 152: 946-951.
28. Wright RO, Lewander WJ, Woolf AD (1999) Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med 34: 646-656.
29. Lomniczi A, Cebral E, Canteros G, McCann SM, Rettori V (2000) Methylene blue inhibits the increase of inducible nitric oxide synthase activity induced by stress and lipopolysaccharide in the medial basal hypothalamus of rats. Neuroimmunomodulation 8: 122-127.
30. Bruno MJ (2003) Magnification endoscopy, high resolution endoscopy, and chromoscopy; towards a better optical diagnosis. Gut 52 Suppl 4: iv7-11.
31. Kiesslich R, Jung M, DiSario JA, Galle PR, Neurath MF (2004) Perspectives of chromo and magnifying endoscopy: how, how much, when, and whom should we stain? J Clin Gastroenterol 38: 7-13.
32. Peter C, Hongwan D, Kupfer A, Lauterburg BH (2000) Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol 56: 247-250.
33. Kirszberg C, Rumjanek VM, Capella MA (2005) Methylene blue is more toxic to erythroleukemic cells than to normal peripheral blood mononuclear cells: a possible use in chemotherapy. Cancer Chemother Pharmacol 56: 659-665.
34. Chang YS, Tseng SY, Tseng SH, Chen YT, Hsiao JH (2005) Comparison of dyes for cataract surgery. Part 1: cytotoxicity to corneal endothelial cells in a rabbit model. J Cataract Refract Surg 31: 792-798.
35. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227.
36. Harbrecht BG, Wu B, Watkins SC, Billiar TR, Peitzman AB (1997) Inhibition of nitric oxide synthesis during severe shock but not after resuscitation increases hepatic injury and neutrophil accumulation in hemorrhaged rats. Shock 8: 415-421.
37. Scalia R, Armstead VE, Minchenko AG, Lefer AM (1999) Essential role of Pselectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion. J Exp Med 189: 931-938.
38. Kanzler I, Tuchscheerer N, Steffens G, Simsekyilmaz S, Konschalla S, et al. (2013) Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis. Basic Res Cardiol 108: 310.
39. Carreau A, Kieda C, Grillon C (2011) Nitric oxide modulates the expression of endothelial cell adhesion molecules involved in angiogenesis and leukocyte recruitment. Exp Cell Res 317: 29-41.
40. Miller J, Knorr R, Ferrone M, Houdei R, Carron CP, et al. (1995) Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J Exp Med 182: 1231-1241.
41. Yang L, Kowalski JR, Yacono P, Bajmoczi M, Shaw SK, et al. (2006) Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration. J Immunol 177: 6440-6449.
42. Barreiro O, Yanez-Mo M, Serrador JM, Montoya MC, Vicente-Manzanares M, et al. (2002) Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J Cell Biol 157: 1233-1245.
43. Carman CV, Springer TA (2004) A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol 167: 377-388.
44. Xu PB, Lou JS, Ren Y, Miao CH, Deng XM (2012) Gene expression profiling reveals the defining features of monocytes from septic patients with compensatory anti-inflammatory response syndrome. J Infect 65: 380-391.
45. Cho JS, Song JW, Na S, Moon JH, Kwak YL (2012) Effect of a single bolus of methylene blue prophylaxis on vasopressor and transfusion requirement in infective endocarditis patients undergoing cardiac surgery. Korean J Anesthesiol 63: 142-148.
46. Bath PM (1993) The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro. Eur J Clin Pharmacol 45: 53-58.
47. Belenky SN, Robbins RA, Rubinstein I (1993) Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J Leukoc Biol 53: 498-503.
48. Wang W, Jiang D, Zhu Y, Liu W, Duan J, et al. (2009) Relaxing effects of phytoestrogen alpha-zearalanol on rat thoracic aorta rings in vitro. Chin J Physiol 52: 99-105.
49. Thiemermann C, Szabo C, Mitchell JA, Vane JR (1993) Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci U S A 90: 267-271.
50. Lange M, Connelly R, Traber DL, Hamahata A, Nakano Y, et al. (2010) Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model. Crit Care 14: R129.
51. Evora PR, Evora PM, Celotto AC, Rodrigues AJ, Joviliano EE (2012) Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview. Curr Drug Targets 13: 1207-1214.